Multiplexed-engineered CAR NK Cell Product Candidate derived from Clonal Master iPSC Line that incorporates Four Functional Elements, including a Novel CAR Targeting the Pan-tumor Associated Stress ...
Program Incorporates New CAR Constructs Designed to Specifically Target the Pan-tumor Associated Stress Proteins MICA and MICB Proprietary Binding Domains Shown to Overcome MICA/B Shedding, a Common ...
Cancer vaccines have improved dramatically over the past decade thanks to novel vaccine platforms and methods of antigen identification. However, there are still important challenges to their success.
(MENAFN- GlobeNewsWire - Nasdaq) SAN DIEGO, Oct. 01, 2021 (GLOBE NEWSWIRE) -- Fate Therapeutics, Inc. (NASDAQ: FATE), a clinical-stage biopharmaceutical company dedicated to the development of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results